Ticker,Title,Link
DVAX,"Dynavax Buy Rating Affirmed Despite Q2 Revenue Shortfall, Future Growth Anticipated",8/7/2024 10:43:01 AM
DVAX,"Dynavax GAAP EPS of $0.08 beats by $0.02, revenue of $73.8M misses by $2.24M",8/6/2024 8:05:29 PM
DVAX,Dynavax Technologies is about to announce earnings — here's what Wall Street expects,8/5/2024 3:01:13 PM
DVAX,Dynavax’s Promising Vaccine Trials and Financial Outlook Merit a Buy Rating,6/28/2024 10:16:02 AM
DVAX,"Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Dynavax (DVAX) and Natera (NTRA)",5/14/2024 5:30:15 PM
DVAX,"Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), NeuroPace (NPCE) and Dynavax (DVAX)",5/9/2024 10:30:51 AM
DVAX,Dynavax drops 6% as quarterly results miss on both lines,5/8/2024 9:45:39 PM
DVAX,Dynavax Q1 2024 Earnings Preview,5/7/2024 9:20:42 PM
DVAX,"Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more",5/5/2024 12:00:00 PM
DVAX,Biotech Stocks Facing FDA Decision In May 2024 ,4/30/2024 7:47:54 PM
DVAX,Dynavax’s Strong Financial Outlook and Heplisav-B Market Expansion Prompt ‘Buy’ Rating,2/23/2024 2:45:31 PM
DVAX,"Dynavax GAAP EPS of $0.00 beats by $0.01, revenue of $55.6M beats by $2.87M",2/22/2024 9:02:21 PM
DVAX,Dynavax Q4 2023 Earnings Preview,2/21/2024 10:20:36 PM
DVAX,Small cap value stocks with potential M&A candidacy - BofA,2/16/2024 4:10:43 PM
DVAX,Dynavax Hold Rating: Solid Performance Counterbalanced by Priced-In Prospects,2/1/2024 7:16:39 AM
DVAX,"Analysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Dynavax (DVAX)",1/9/2024 2:10:30 PM
DVAX,Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session,1/8/2024 7:36:31 PM
DVAX,Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference,11/20/2023 11:04:00 PM
DVAX,Dynavax: Solid Financial Performance and Promising Growth Prospects Bolster Buy Rating,11/3/2023 10:18:24 AM
DVAX,Dynavax Technologies is about to announce earnings — here's what Wall Street expects,11/1/2023 3:01:13 PM
DVAX,"Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023",10/26/2023 10:15:00 PM
DVAX,Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference,10/19/2023 7:15:00 PM
DVAX,H.C. Wainwright Keeps Their Buy Rating on Dynavax (DVAX),9/18/2023 10:15:27 AM
DVAX,"Cramer Suggests Buying Fast Food Chain Owner Of Popeye's, Burger King: Here's Why",9/7/2023 2:34:48 PM
DVAX,Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference,9/6/2023 10:05:00 PM
DVAX,"Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday",8/4/2023 4:32:24 PM
DVAX,"Dynavax GAAP EPS of $0.03 beats by $0.12, revenue of $60.25M beats by $11.87M",8/3/2023 8:36:01 PM
DVAX,Dynavax Q2 2023 Earnings Preview,8/2/2023 9:35:51 PM
DVAX,"Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023",7/20/2023 10:15:00 PM
DVAX,JMP Securities Sticks to Its Buy Rating for Dynavax (DVAX),6/6/2023 8:35:38 PM
DVAX,The 7 Best Stocks Under $15 to Buy in June 2023,6/1/2023 11:52:40 PM
DVAX,Dynavax to Present at Upcoming Investor Conferences,5/30/2023 10:15:00 PM
DVAX,Dynavax to Present at the JMP Securities Life Sciences Conference,5/8/2023 10:15:00 PM
DVAX,The Latest Analyst Ratings for Dynavax Technologies,5/3/2023 8:01:45 PM
DVAX,Goldman Sachs Sticks to Its Buy Rating for Dynavax (DVAX),5/2/2023 11:55:19 PM
DVAX,Notable earnings after Tuesday's close,5/1/2023 9:35:24 PM
DVAX,"Dynavax to Report First Quarter 2023 Financial Results and Host Conference Call on May 2, 2023",4/18/2023 10:15:00 PM
DVAX,7 Biotech Stocks Sitting in the Sweet Spot,3/24/2023 10:30:57 AM
DVAX,The Top 7 Growth Stocks in Biotech,3/3/2023 11:57:06 PM
DVAX,Dynavax to Present at the Cowen 43rd Annual Health Care Conference,3/1/2023 10:15:00 PM
DVAX,Analysts Offer Insights on Healthcare Companies: Dynavax (DVAX) and Blackmores Limited (OtherBLMMF),2/28/2023 3:50:04 PM
DVAX,JMP Securities Maintains Market Outperform Rating for Dynavax Technologies: Here's What You Need To Know,2/24/2023 6:00:49 PM
DVAX,"Dynavax GAAP EPS of $0.45 in-line, revenue of $184.49M beats by $6.11M",2/23/2023 9:11:24 PM
DVAX,Dynavax Technologies earnings: here's what Wall Street expects,2/22/2023 3:01:13 PM
DVAX,"Dynavax to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023",2/9/2023 10:15:00 PM
DVAX,Dynavax Announces Uplisting to the Nasdaq Global Select Market,1/31/2023 10:15:00 PM
DVAX,Jim Cramer On This Stock Up 2% Over 6 Months: 'You've Got A Real Winner There',1/20/2023 3:01:31 PM
DVAX,The 7 Most Undervalued Long-Term Stocks to Buy in January,1/14/2023 9:03:39 PM
DVAX,JMP Securities Keeps Their Buy Rating on Dynavax (DVAX),1/11/2023 3:05:15 PM
DVAX,H.C. Wainwright Reaffirms Their Buy Rating on Dynavax (DVAX),1/10/2023 11:15:10 AM
DVAX,Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Highlights and Phase 1 Shingles Topline Results,1/9/2023 2:00:00 PM
DVAX,7 Cheap Stocks That Wall Street Analysts Still Love,1/6/2023 7:00:57 PM
DVAX,The 7 Most Undervalued Long-Term Stocks to Buy Now,12/18/2022 10:12:08 PM
DVAX,Our 7 Top Small-Cap Stock Picks for 2023,12/12/2022 3:48:06 PM
DVAX,Valneva dips as French health authority advises against COVID shot,12/8/2022 12:09:57 PM
DVAX,Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission,11/30/2022 3:10:11 PM
DVAX,Dynavax to Present at Two Upcoming Investor Conferences,11/9/2022 10:05:00 PM
DVAX,"Analysts’ Top Healthcare Picks: Dynavax (DVAX), Iovance Biotherapeutics (IOVA)",11/4/2022 10:21:03 AM
DVAX,"Dynavax GAAP EPS of $0.43 beats by $0.10, revenue of $167.74M beats by $8.33M",11/3/2022 8:16:00 PM
DVAX,Here's what to expect from Dynavax Technologies's earnings,11/2/2022 3:01:13 PM
DVAX,JMP Securities Keeps Their Buy Rating on Dynavax (DVAX),10/26/2022 9:26:16 PM
DVAX,"Analysts Are Bullish on These Healthcare Stocks: Dynavax (DVAX), Jazz Pharmaceuticals (JAZZ)",10/25/2022 6:20:29 PM
DVAX,"Dynavax to Report Third Quarter Financial Results and Host Conference Call on November 3, 2022",10/20/2022 10:05:00 PM
DVAX,Dynavax to Present at the H.C. Wainwright 3rd Annual Hepatitis B Virus Virtual Conference,10/14/2022 10:05:00 PM
DVAX,3 Under-the-Radar Small-Cap Stocks With 100% Upside Potential,10/13/2022 10:24:14 PM
DVAX,"Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022",9/27/2022 4:05:59 PM
DVAX,Short Interest Sector Focus: Healthcare Sector,9/26/2022 4:29:08 PM
DVAX,China-Based COVID-19 Shot Neutralizes Omicron Subvariants,9/20/2022 1:29:33 PM
DVAX,"Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session",9/19/2022 6:29:26 PM
DVAX,7 Small-Cap Stocks to Buy Before September Ends,9/15/2022 3:54:49 PM
DVAX,"Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary",9/13/2022 12:29:44 AM
DVAX,Dynavax Announces First Participant Dosed in a Phase 2 Clinical Trial Evaluating an Adjuvanted Plague Vaccine,9/12/2022 2:00:00 PM
DVAX,Dynavax to Present at the H.C. Wainwright 24th Annual Global Investment Conference,9/8/2022 10:05:00 PM
DVAX,"Clover, Dynavax COVID vaccine booster shot shows better response vs inactivated vaccine",9/6/2022 10:27:10 AM
DVAX,"Clover, Dynavax COVID vaccine shows efficacy against Omicron subvariant BA.5 in trial",8/30/2022 10:03:59 AM
DVAX,Valneva shows booster effect of COVID shot against AstraZeneca vaccine,8/29/2022 1:07:50 PM
DVAX,Recap Of Thursday's Biotech Catalysts - End Of the Day Summary,8/26/2022 12:43:59 AM
DVAX,"Dynavax's Adjuvant Based COVID-19 Shot Shows Robust Immune Response, Safety In Younger Populations",8/25/2022 4:31:20 PM
DVAX,Valneva wins WHO nod for COVID-19 vaccine,8/18/2022 2:31:55 PM
DVAX,"Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats",8/4/2022 9:42:30 PM
DVAX,Dynavax Q2 2022 Earnings Preview,8/3/2022 9:35:56 PM
DVAX,"Dynavax to Report Second Quarter Financial Results and Host Conference Call on August 4, 2022",7/21/2022 10:05:00 PM
DVAX,Valneva agrees to cut COVID vaccine supplies to EU,7/20/2022 3:58:19 PM
DVAX,"Buy these 3 growth stocks that look oversold as investors price in the 'worst-case scenario,' says a portfolio manager at $631 billion Federated Hermes",7/3/2022 11:00:33 AM
DVAX,Clover COVID vaccine's booster shot shows response against Omicron variants,6/27/2022 11:00:27 AM
DVAX,Valneva announces European approval of COVID-19 vaccine,6/24/2022 4:22:31 PM
DVAX,Valneva adds 32% on European recommendation for COVID-19 shot,6/23/2022 1:37:09 PM
DVAX,Valneva plunges amid concerns over future of COVID-19 shot in Europe,6/13/2022 2:39:45 PM
DVAX,Dynavax to Present at the William Blair 42nd Annual Growth Stock Conference,5/25/2022 10:05:00 PM
DVAX,Dynavax to Present at the H.C. Wainwright Global Investment Conference,5/16/2022 10:10:00 PM
DVAX,56 Stocks Moving In Friday's Mid-Day Session,5/13/2022 6:12:34 PM
DVAX,"Dynavax GAAP EPS of $0.26 beats by $0.02, revenue of $114M misses by $40.29M",5/5/2022 8:06:13 PM
DVAX,Notable earnings after Thursday's close,5/4/2022 9:35:55 PM
DVAX,Valneva slips on request for more data to support EU nod for COVID-19 shot,4/25/2022 1:15:38 PM
DVAX,"Dynavax to Report First Quarter 2022 Financial Results and Host Conference Call on May 5, 2022",4/21/2022 10:05:00 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),4/5/2022 10:02:00 PM
DVAX,Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron,3/17/2022 2:41:18 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),3/8/2022 10:05:00 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),3/3/2022 10:05:00 PM
DVAX,"Dynavax GAAP EPS of $0.55 misses by $0.09, revenue of $195.07M misses by $13.8M",2/28/2022 9:10:06 PM
DVAX,Notable earnings after Monday's close,2/27/2022 10:35:02 PM
DVAX,Dynavax to Present at the Cowen 42nd Annual Health Care Conference,2/23/2022 10:05:00 PM
DVAX,"Dynavax to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 28, 2022",2/16/2022 10:05:00 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),2/2/2022 10:05:00 PM
DVAX,"Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows",1/19/2022 6:53:08 PM
DVAX,Dynavax Highlights 2022 Priorities and Announces Initiation of Phase 1 Clinical Trial for Its Shingles Vaccine Candidate,1/10/2022 2:00:00 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),1/7/2022 10:05:00 PM
DVAX,"Dynavax reinstated Buy at Goldman Sachs on potential of adjuvant, HBV prospects",1/6/2022 2:04:15 PM
DVAX,Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference,1/5/2022 10:05:00 PM
DVAX,Dynavax target raised at H.C. Wainwright after India OK’d COVID-19 shot based on adjuvant,12/29/2021 8:38:59 PM
DVAX,COVID-19 Vaccine Developed by Biological E Using Dynavax's CpG 1018 Adjuvant Receives India DCGI Approval for Emergency Use,12/28/2021 5:34:00 PM
DVAX,Is Israel's fourth COVID vaccine dose a sign of things to come?,12/22/2021 10:44:14 AM
DVAX,Elaine D. Sun Appointed to Dynavax Board of Directors,12/14/2021 2:10:00 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/2/2021 10:05:00 PM
DVAX,Valneva in pact with IDT Biologika for production of COVID-19 vaccine candidate,11/29/2021 5:07:21 PM
DVAX,Why Are Valneva Shares Trading Higher Today?,11/23/2021 7:15:41 PM
DVAX,Dynavax to Present at the 4th Annual Evercore Virtual ISI HealthCONx Conference,11/18/2021 10:10:00 PM
DVAX,Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal,11/10/2021 6:22:37 PM
DVAX,92 Biggest Movers From Friday,11/8/2021 9:42:50 AM
DVAX,64 Stocks Moving In Friday's Mid-Day Session,11/5/2021 5:24:13 PM
DVAX,"Dynavax EPS misses by $0.29, beats on revenue",11/4/2021 8:06:58 PM
DVAX,Dynavax Q3 2021 Earnings Preview,11/3/2021 9:35:50 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/2/2021 9:10:00 PM
DVAX,Scott Myers Appointed to Dynavax Board of Directors and Elected Board Chairman,10/21/2021 10:20:00 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/18/2021 11:43:00 PM
DVAX,Ocugen gains as partnered COVID-19 vaccine gets emergency use nod for kids in India,10/12/2021 10:52:37 AM
DVAX,Dynavax and U.S. Department of Defense Announce Collaboration to Develop an Adjuvanted Plague Vaccine Using Dynavax's CpG 1018 Adjuvant,10/4/2021 2:00:00 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/2/2021 12:13:00 AM
DVAX,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",9/28/2021 2:18:52 PM
DVAX,Dynavax to Present at Upcoming Investment Conferences,9/27/2021 10:20:00 PM
DVAX,"Biotech's big fall catalysts to watch out for, from Evercore",9/24/2021 1:35:37 PM
DVAX,50 Biggest Movers From Yesterday,9/23/2021 11:14:45 AM
DVAX,Why Are Dynavax Technologies Shares Skyrocketing Today?,9/22/2021 6:19:34 PM
DVAX,72 Biggest Movers From Yesterday,9/14/2021 10:50:31 AM
DVAX,45 Stocks Moving In Monday's Mid-Day Session,9/13/2021 6:02:33 PM
DVAX,Dynavax to Present at the H.C. Wainwright 23rd Annual Global Investment Conference,9/9/2021 10:02:00 PM
DVAX,The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week,9/5/2021 7:14:08 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),9/2/2021 10:02:00 PM
DVAX,"The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering",9/1/2021 1:32:13 PM
DVAX,"The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical",8/31/2021 2:06:37 PM
DVAX,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",8/27/2021 1:35:25 PM
DVAX,"The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO",8/26/2021 2:09:14 PM
DVAX,"The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug",8/25/2021 1:30:14 PM
DVAX,60 Biggest Movers From Yesterday,8/24/2021 11:11:29 AM
DVAX,"Powered By Dynavax Adjuvant, Medigen COVID-19 Vaccine Launched In Taiwan",8/23/2021 5:50:11 PM
DVAX,Dynavax underperforms as insider selling picks up,8/20/2021 1:30:40 PM
DVAX,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",8/13/2021 1:43:02 PM
DVAX,"The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma",8/12/2021 2:09:26 PM
DVAX,"The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts",8/10/2021 1:55:36 PM
DVAX,"Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021",8/6/2021 4:06:00 PM
DVAX,10 Biggest Price Target Changes For Thursday,8/5/2021 2:10:00 PM
DVAX,Dynavax Announces Second Quarter 2021 Financial Results,8/4/2021 10:02:00 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),8/3/2021 10:10:00 PM
DVAX,Here's what to expect from Dynavax Technologies's earnings,8/2/2021 3:02:05 PM
DVAX,"The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs",8/1/2021 4:13:48 PM
DVAX,"Vaccine mandates announced in NYC, California and Department of Veterans Affairs",7/27/2021 10:45:49 AM
DVAX,"Dynavax to Report Second Quarter 2021 Financial Results and Host Conference Call on August 4, 2021",7/21/2021 10:02:00 PM
DVAX,Biological E To Buy Dynavax's CpG 1018 Adjuvant For COVID-19 Vaccine Candidate ,7/6/2021 2:24:50 PM
DVAX,Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),7/2/2021 10:05:00 PM
DVAX,"Clover, Dynavax Ink Commercial Supply Agreement For CpG 1018 Adjuvant",6/30/2021 5:04:51 PM
DVAX,Dynavax Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),6/29/2021 10:05:00 PM
DVAX,Will coronavirus eventually become like the seasonal flu?,6/20/2021 1:19:22 PM
DVAX,Valneva Concludes Recruitment for COVID-19 Vaccine Candidate Trial,6/3/2021 9:32:10 PM
DVAX,"Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany",5/27/2021 2:47:38 PM
DVAX,India's Biological E To Make Johnson & Johnson's COVID-19 Shots: Reuters,5/19/2021 1:09:13 PM
DVAX,Clover Bio's COVID-19 vaccine candidate shows immune response against SARS-CoV-2 variants in mouse model,5/18/2021 4:50:19 AM
DVAX,64 Biggest Movers From Yesterday,5/11/2021 11:03:08 AM
DVAX,40 Stocks Moving In Monday's Mid-Day Session,5/10/2021 6:02:37 PM
DVAX,Dynavax rallies on Q1 strong revenue led by CpG 1018 product revenue,5/7/2021 3:53:56 PM
DVAX,"Dynavax EPS beats by $0.03, beats on revenue",5/6/2021 8:05:29 PM
DVAX,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",5/1/2021 7:19:25 PM
DVAX,Dynavax presents HEPLISAV-B study results at ACVR 2021 Annual Conference,4/27/2021 1:04:12 PM
DVAX,EU sees potential in protein-based COVID-19 vaccines,4/23/2021 1:44:39 PM
DVAX,Valneva initiates pivotal late-stage COVID-19 vaccine trial,4/21/2021 8:08:42 PM
DVAX,"Purple Biotech, NeuroBo Pharmaceuticals leads healthcare gainers; Syndax Pharmaceuticals, Zai Lab among major losers",4/20/2021 2:58:32 PM
DVAX,Valneva's COVID-19 Vaccine Candidate Using Dynavax's Adjuvant Shows Positive Interim Results,4/6/2021 3:38:34 PM
DVAX,"The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping",3/24/2021 1:59:18 PM
DVAX,72 Biggest Movers From Friday,3/1/2021 10:56:51 AM
DVAX,Dynavax surges on prospects for COVID–19 vaccine adjuvant,2/26/2021 6:51:22 PM
DVAX,"Dynavax EPS beats by $0.10, beats on revenue",2/25/2021 9:09:52 PM
DVAX,Dynavax Technologies earnings: here's what Wall Street expects,2/23/2021 3:01:52 PM
DVAX,"The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings",2/20/2021 3:36:28 PM
DVAX,Dynavax wins European approval for Hep B vaccine,2/19/2021 5:47:16 PM
DVAX,Could a COVID vaccine passport be issued in the U.K.?,2/15/2021 11:43:24 AM
DVAX,"The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement",2/9/2021 2:10:28 PM
DVAX,"Dynavax, Serum Institute Start Phase 1 Trial For Tdap Booster Vaccine",2/4/2021 5:03:46 PM
DVAX,"Ocugen, Cassava Sciences leads healthcare gainers; Immunovant, Dynavax Technologies among major losers",2/2/2021 3:57:26 PM
DVAX,Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Viela Bio Shares Spike Higher,2/1/2021 8:36:49 PM
DVAX,10 Short Squeeze Candidates Under $10,1/30/2021 2:37:57 PM
DVAX,84 Biggest Movers From Yesterday,1/26/2021 11:15:26 AM
DVAX,"Medigen, Dynavax start dosing in mid-stage COVID-19 vaccine trial",1/25/2021 6:09:10 PM
DVAX,"The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping",1/21/2021 2:05:24 PM
DVAX,Dynavax Technologies names new finance chief,1/20/2021 9:27:47 PM
DVAX,Dynavax's Hepatitis B vaccine shows encouraging action in ongoing hemodialysis trial,1/7/2021 4:45:11 PM
DVAX,Novavax next in line to offer COVID-19 vaccine alternatives - SVB Leerink,1/5/2021 5:27:40 PM
DVAX,Israel leads world in COVID vaccinations per capita,1/1/2021 1:07:48 PM
DVAX,"The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks",12/26/2020 3:15:52 PM
DVAX,Dosing underway in Dynavax's mid-stage study of COVID-19 vaccine,12/23/2020 1:27:07 PM
DVAX,Will vaccines work against the U.K. coronavirus variant?,12/22/2020 10:00:56 AM
DVAX,Dynavax rises 4% as EMA backs marketing application for HEPLISAV-B,12/11/2020 9:48:15 AM
DVAX,U.K. rolls out COVID-19 vaccine to public - report,12/8/2020 8:41:39 AM
DVAX,Clover Bio's COVID-19 vaccine candidates in combination with GSK or Dynavax's adjuvants show positve early-stage data,12/4/2020 8:30:48 AM
DVAX,Vaccine access and distribution a big topic at G20,11/22/2020 2:12:08 PM
DVAX,FDA plans early advisory meetings in December to discuss COVID-19 vaccines - CNBC,11/19/2020 10:02:20 AM
DVAX,"Moderna shares jump 12% as COVID-19 vaccine shows 94.5% efficacy, expects EUA submission shortly",11/16/2020 12:20:35 PM
DVAX,"Pfizer/BioNTech COVID-19 vaccine 90% effective, U.S. EUA application expected this month",11/9/2020 12:07:49 PM
DVAX,"ACB, TTD, TLRY and NET among premarket gainers",11/6/2020 1:22:04 PM
DVAX,"Dynavax EPS beats by $0.05, beats on revenue",11/5/2020 9:04:20 PM
DVAX,"Week Ahead In Pharma: COVID-19 Data Readout, FDA Decisions, CTAD Presentation ",11/1/2020 11:00:11 AM
DVAX,7 Penny Stocks to Watch in November,10/30/2020 12:14:32 PM
DVAX,"U.S. COVID-19 cases on the rise, key vaccine data expected in November",10/28/2020 4:39:57 PM
DVAX,FDA getting cold feet on EUA nod for COVID-19 vaccines,10/23/2020 3:25:03 PM
DVAX,FDA Ad Com tomorrow on development/authorization of COVID-19 vaccines,10/21/2020 5:43:16 PM
DVAX,Moderna not far behind Pfizer on vaccine emergency authorization,10/20/2020 7:18:42 AM
DVAX,Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets,10/19/2020 4:58:50 PM
DVAX,"NIO, MDRX, SRNE and DVAX among midday movers",10/14/2020 4:38:41 PM
DVAX,Microcaps mostly among premarket gainers list,10/13/2020 12:20:14 PM
DVAX,Head of Operation Warp Speed sees emergency authorization vaccine request around Thanksgiving,10/12/2020 10:48:20 AM
DVAX,FDA Ad Com this month to clarify COVID-19 vaccine authorization requirements,10/6/2020 2:12:30 PM
DVAX,"Pre-market Movers In Healthcare Sector: IMMU, SAVA, DVAX, ENLV, VXRT... ",9/14/2020 12:28:59 PM
DVAX,Dynavax to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference,8/31/2020 10:10:10 PM
DVAX,"Pre-market Movers In Healthcare Sector: TFFP, NVAX, KMDA, PRPO, DVAX... ",8/14/2020 12:26:32 PM
DVAX,Dynavax Gets Funding From Bill & Melinda Gates Foundation To Support Development Of COVID-19 Vaccine ,8/13/2020 2:37:25 PM
DVAX,Earnings-related names dominate premarket losers,8/7/2020 12:18:51 PM
DVAX,Dynavax Announces Second Quarter 2020 Financial Results,8/6/2020 10:02:10 PM
DVAX,Here's what Wall Street expects from Dynavax Technologies's earnings report,8/5/2020 3:04:13 PM
DVAX,TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales,8/3/2020 2:00:10 PM
DVAX,"Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020",7/30/2020 10:05:10 PM
DVAX,"Dynavax, Medigen Collaborate To Develop Adjuvanted COVID-19 Vaccine Candidate ",7/23/2020 2:49:33 PM
DVAX,Dynavax Announces the Appointment of Two New Board Members,7/21/2020 10:10:10 PM
DVAX,Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant,7/16/2020 2:40:10 PM
DVAX,Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 Vaccine Candidate with Dynavax’s CpG 1018 Adjuvant,7/14/2020 2:00:10 PM
DVAX,"Dynavax and Times Pharmacy Announce Partnership to Offer HEPLISAV-B® Hepatitis B Vaccine to Customers Throughout Oahu, with a Focus on People with Diabetes",7/10/2020 10:01:10 PM
DVAX,Dynavax and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate,7/8/2020 8:30:00 AM
DVAX,Be Careful with Novavax and the Recent Surge in NVAX Stock,6/29/2020 12:00:45 PM
DVAX,Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series,6/22/2020 3:00:10 PM
DVAX,Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant,6/19/2020 12:00:10 PM
DVAX,Race For COVID-19 Vaccine: Who Are The Key Players? ,6/13/2020 9:22:12 AM
DVAX,7 Great Biotech Stocks to Buy and Hold Now,6/11/2020 2:55:31 PM
DVAX,Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis,6/9/2020 2:00:10 PM
DVAX,Non-Warp Speed COVID-19 vaccine players under pressure,6/3/2020 7:29:00 PM
DVAX,"NTLA Gains On Amended REGN Deal, GILD Reports SIMPLE Results, MYOV On Watch, NVUS Slumps ",6/2/2020 6:27:39 AM
DVAX,"'99%' chance Covid-19 vaccine will be effective, Sinovac claims",5/29/2020 4:34:10 PM
DVAX,Dynavax to Present at the William Blair 40th Annual Growth Stock Conference,5/28/2020 10:05:10 PM
DVAX,Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares,5/27/2020 10:05:10 PM
DVAX,"FL, HPE among premarket losers",5/22/2020 1:19:19 PM
DVAX,Dynavax Technologies Announces Proposed Public Offering of Common Stock ,5/21/2020 10:01:10 PM
DVAX,"DVAX, ABUS, ACB and SRNE among midday movers",5/19/2020 4:45:17 PM
DVAX,Dynavax Announces First Quarter 2020 Financial Results,5/7/2020 10:10:10 PM
DVAX,Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis,4/28/2020 10:10:10 PM
DVAX,"Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020",4/23/2020 10:10:10 PM
DVAX,"Dynavax, Sinovac Collaborate To Develop COVID-19 Vaccine - Quick Facts ",4/16/2020 1:56:37 PM
DVAX,"Dynavax Donates 10,000 Doses of HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Vaccine to Emergency Healthcare Providers and Hospital Staff to Protect Against Hepatitis B Infections...",4/8/2020 2:00:10 PM
DVAX,Dynavax Provides Business Update on COVID-19 Pandemic Impact,4/2/2020 10:30:00 PM
DVAX,Stock Alert: Dynavax Shares Rise 11% In Early Trading ,3/26/2020 2:06:36 PM
DVAX,Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant,3/24/2020 1:30:00 PM
DVAX,Profit-taking pressures Moderna after Hahn comments on vaccine timeline,3/19/2020 5:00:38 PM
DVAX,First American may receive coronavirus vaccine soon - Fauci,3/12/2020 4:40:12 PM
DVAX,Dynavax Announces Fourth Quarter and Full Year 2019 Financial Results,3/11/2020 9:10:00 PM
DVAX,Dynavax Technologies earnings: here's what Wall Street expects,3/10/2020 3:01:25 PM
DVAX,"Coronavirus plays - vaccines, drugs & infection control products",3/3/2020 6:42:24 PM
DVAX,"TSLA, TWTR among premarket gainers",3/2/2020 2:16:02 PM
DVAX,Dynavax to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 11,2/24/2020 10:05:00 PM
DVAX,Dynavax to Present at the Cowen 40th Annual Health Care Conference,2/18/2020 10:05:00 PM
DVAX,"While Risks Remain, VBI Vaccines Stock Is a Buy at Today’s Prices",2/5/2020 7:45:27 PM
DVAX,Is It Time to Go Long on VBIV Stock?,1/30/2020 1:22:31 PM
DVAX,Dynavax Appoints Ryan Spencer as Chief Executive Officer and to Board of Directors,12/16/2019 10:15:00 PM
DVAX,Dynavax Announces Partnership with Albertsons Companies’ Pharmacies to Offer HEPLISAV-B® Hepatitis B Vaccine to Patients Nationwide,12/5/2019 2:00:00 PM
DVAX,Dynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report Completed,12/3/2019 1:00:00 PM
DVAX,Dynavax to Present at the Stifel 2019 Healthcare Conference ,11/7/2019 10:05:00 PM
DVAX,Dynavax Announces Third Quarter 2019 Financial Results,11/6/2019 10:05:00 PM
DVAX,7 “Strong Buy” Stocks With Triple-Digit Growth Prospects,10/31/2019 3:19:00 PM
DVAX,Dynavax to Report Third Quarter 2019 Financial Results and Host Conference Call on November 6,10/24/2019 10:05:05 PM
DVAX,Dynavax to Present at the 2019 Cantor Global Healthcare Conference,9/30/2019 10:05:00 PM
DVAX,"Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors",8/12/2019 10:05:00 PM
DVAX,"Dynavax Technologies Announces Pricing of $70.1 Million Public Offering of Common Stock, Non Voting Preferred Stock and Warrants to Purchase Common Stock",8/8/2019 2:00:00 PM
DVAX,"Dynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common Stock",8/7/2019 10:12:46 PM
DVAX,Here's what Wall Street expects from Dynavax Technologies's earnings report,8/5/2019 3:03:10 PM
DVAX,Dynavax Technologies to Report Second Quarter 2019 Financial Results and Host Conference Call on August 7,7/24/2019 10:05:00 PM
DVAX,Dynavax to Present at the William Blair & Co. Annual Growth Stock Conference  ,6/3/2019 10:05:00 PM
DVAX,Dynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Head and Neck Squamous Cell Carcinoma at the 2019 ASCO Annual Meeting,6/1/2019 8:15:00 PM
DVAX,Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business,5/23/2019 10:45:00 PM
DVAX,Dynavax Announces First Quarter 2019 Financial Results,5/8/2019 10:05:00 PM
DVAX,Dynavax Technologies earnings preview: what Wall Street is expecting,5/6/2019 3:02:38 PM
DVAX,"Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B® [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in Adults With End-Stage Renal Disease",5/2/2019 11:00:00 PM
DVAX,Dynavax Technologies to Report First Quarter 2019 Financial Results  and Host Conference Call on May 8,4/25/2019 10:05:00 PM
DVAX,Dynavax to Present Data on Toll-like Receptor 9 Agonist SD-101 at the ASCO Annual Meeting 2019,4/18/2019 10:05:00 PM
DVAX,Dynavax Presents Phase 1b Data on Inhaled DV281 TLR9 Agonist at the 2019 AACR Annual Meeting,4/2/2019 7:00:00 PM
DVAX,Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Response in Preclinical Models,4/1/2019 7:00:00 PM
DVAX,AACR 2019 - Keep An Eye On These Biotech Stocks ,3/31/2019 6:11:44 PM
DVAX,Dynavax Announces European Medicines Agency Accepts Marketing Authorization Application for HEPLISAV-B® for Prevention of Hepatitis B in Adults,3/28/2019 9:05:00 PM
DVAX,Dynavax to Present on Inhaled TLR9 Agonist DV281 at the AACR Annual Meeting 2019,3/20/2019 9:20:00 PM
DVAX,Dynavax Exercises Option for $75 Million in Non-Dilutive Debt,3/18/2019 9:05:00 PM
DVAX,Dynavax to Present at 39th Annual Cowen Healthcare Conference,3/6/2019 10:05:00 PM
DVAX,Dynavax Announces Fourth Quarter and Full Year 2018 Financial Results,2/26/2019 10:05:00 PM
DVAX,Here's what to expect from Dynavax Technologies's earnings,2/24/2019 3:01:31 PM
DVAX,Dynavax Technologies to Report Fourth Quarter and Full Year 2018 Financial Results  and Host Conference Call on February 26,2/12/2019 10:05:00 PM
DVAX,Heather Rowe Named Dynavax’s Vice President of Investor Relations and Corporate Communications,1/29/2019 10:05:00 PM
DVAX,"Sam’s Club and Dynavax Technologies Corporation Announce Collaboration to Make HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Available to Sam’s Club Patients",1/8/2019 3:00:00 PM
DVAX,Dynavax to Present at 37th Annual J.P. Morgan Healthcare Conference,1/3/2019 10:05:00 PM
DVAX,"Dynavax Reports Third Quarter 2018 Financial Results, Progress on HEPLISAV-B Launch, and Updated SD-101 Data in Three Patient Populations",11/5/2018 10:01:00 PM
DVAX,Dynavax Technologies is about to announce earnings — here's what Wall Street expects,11/3/2018 3:01:32 PM
DVAX,Dynavax to Host Third Quarter 2018 Financial Results Conference Call,10/29/2018 11:00:00 AM
DVAX,"PETX On The Move, TTOO To Report Q3 Results On Nov.1, CLGN Inks Deal With UTHR ",10/23/2018 2:57:19 AM
DVAX,"FDA Extends Date On BMY's SBLA, Genmab Meets Phase 3 Goals, NCNA, LPTX On Watch ",10/22/2018 5:43:33 AM
DVAX,Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab) Continues to Show a 70% Overall Response Rate in Advanced Melanoma Patients According to Data Presented Today at the ESMO 2018 Congress,10/20/2018 2:45:00 PM
DVAX,Dynavax Technologies and Quantum Leap Healthcare Collaborative Announce Selection of SD-101 Combined with KEYTRUDA® (pembrolizumab) in the I-SPY 2 TRIAL For Breast Cancer,10/15/2018 12:00:00 PM
DVAX,Dynavax to Present New Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) at the European Society for Medical Oncology 2018 Congress,10/9/2018 12:00:00 PM
DVAX,Dynavax to Present at the 2018 Cantor Global Healthcare Conference,9/27/2018 10:01:00 PM
DVAX,Dynavax Announces Publication of Preclinical Study of TLR9 Agonist in Lung Cancer,9/4/2018 12:30:00 PM
DVAX,"Dynavax Announces Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 Agonist, SD-101",8/28/2018 12:30:00 PM
DVAX,Dynavax Reports Second Quarter 2018 Financial Results,8/6/2018 10:01:00 PM
DVAX,Dynavax Technologies earnings preview: what to expect,8/4/2018 3:01:29 PM
DVAX,Dynavax to Host Second Quarter 2018 Financial Results Conference CallUpdate on HEPLISAV-B® and Timing of Oncology Data,7/30/2018 8:45:00 PM
DVAX,Dynavax Appoints Scientific Advisory Board to Support its Oncology and Vaccine ProgramsBoard Comprises Six Members with Notable Contributions to the Fields of Oncology and Immunology,6/28/2018 12:30:00 PM
DVAX,Dynavax Presents Analysis of Data for Participants Aged 60 to 70 with Diabetes from its Phase 3 Trial of HEPLISAV-B®,6/25/2018 6:05:00 PM
DVAX,Dynavax to Present at the William Blair 38th Annual Growth Stock Conference,6/11/2018 12:30:00 PM
DVAX,Dynavax Reports Data for Phase 1b/2 Trial of SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting,6/4/2018 8:15:00 PM
DVAX,Dynavax to Present New Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) at the 2018 American Society for Clinical Oncology Annual Meeting,5/16/2018 11:15:00 PM
DVAX,"ARMO Snapped Up, DEPO Soars On Upbeat Forecast, DPLO Gets A New Boss ",5/11/2018 4:10:13 AM
DVAX,Dynavax Reports First Quarter 2018 Financial Results,5/8/2018 10:05:00 PM
DVAX,Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4),5/7/2018 12:30:00 PM
DVAX,Dynavax to Host First Quarter 2018 Financial Results Conference Call,5/2/2018 10:15:00 PM
DVAX,Dynavax’s HEPLISAV-B® ACIP Recommendations Published in the CDC’s Morbidity and Mortality Weekly ReportHEPLISAV-B Now Meets a Critical Reimbursement Requirement for Many Insurance Plans,4/23/2018 12:30:00 PM
DVAX,Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2018 American Association for Cancer Research Annual Meeting,4/17/2018 3:07:39 PM
DVAX,Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck,4/16/2018 8:10:15 PM
DVAX,"An Ear To The Pharma: 9 Stocks To Watch This Week (RIGL, RARE, TROV, DVAX...) ",4/14/2018 6:20:27 PM
DVAX,The Stagwell Group Acquires ReputationDefender Business Unit from Reputation.com,4/5/2018 4:12:00 PM
DVAX,Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4),4/3/2018 10:30:00 PM
DVAX,Dynavax Announces Acceptance of Two Data Abstracts for SD-101 in Combination with KEYTRUDA® for Presentation at the 2018 American Association for Cancer Research (AACR) Annual Meeting,3/15/2018 11:30:00 AM
DVAX,Dynavax Reports Fourth Quarter and Year End 2017 Financial Results,3/8/2018 12:30:00 PM
DVAX,Dynavax to Present at the Cowen & Co. Annual Health Care Conference,3/5/2018 10:30:00 PM
DVAX,"Stanley A. Plotkin, M.D. Steps Down from Board of Dynavax TechnologiesDr. Plotkin Will Continue as Scientific Advisor",3/2/2018 12:30:00 PM
DVAX,Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4),3/1/2018 10:45:00 PM
DVAX,"ACIP Backs HEPLISAV-B, GMED Hits New High, GWPH's Focal Seizures Trial Fails ",2/22/2018 6:55:22 AM
DVAX,"Dynavax’s HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] Recommended by CDC Advisory Committee on Immunization Practices for the Prevention of Hepatitis B in AdultsHEPLISAV-B is the...",2/21/2018 3:36:41 PM
DVAX,Dynavax Secures $175 Million in Non-Dilutive Debt Financing,2/20/2018 12:30:00 PM
DVAX,Dynavax to Present at the RBC Capital Markets Global Healthcare Conference,2/14/2018 2:00:00 PM
DVAX,Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4),2/2/2018 10:30:00 PM
DVAX,Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4),1/12/2018 10:01:00 PM
DVAX,Dynavax Announces HEPLISAV-B™ is Now Available in the United States  for the Prevention of Hepatitis B in AdultsHEPLISAV-B is the First and Only Two-Dose Vaccine in U.S. for Hepatitis B Prevention...,1/8/2018 12:00:00 PM
DVAX,Dynavax to Present at J.P. Morgan 36th Annual Healthcare Conference,1/4/2018 12:00:00 PM
DVAX,New Drugs Approved In November ,12/8/2017 4:48:10 AM
DVAX,"UPDATE 1-UK Stocks-Factors to watch on Nov 10 (UKX, VED, LSE, STAN, BARC, DVAX, GSK, BRBY, CGS)",11/10/2017 9:27:05 AM
DVAX,"FDA Ruling On DVAX This Week, XNCR On Watch, It's Impressive But Early For AVXL ",11/6/2017 3:02:12 AM
DVAX,BRIEF-Dynavax reports Q3 loss per share $0.38 (DVAX),11/3/2017 11:47:03 AM
DVAX,Biotech Stocks Facing FDA Decision In November ,10/27/2017 11:04:05 AM
DVAX,BRIEF-Dynavax initiates clinical trial in non-small cell lung cancer with a novel inhaled TLR9 Agonist (DVAX),10/19/2017 2:07:13 PM
DVAX,"Deals of the day-Mergers and acquisitions (CDR, DVAX, MC0, N21, PCHEM, RCOM, SEV, 9747)",10/2/2017 11:47:03 AM
DVAX,"Technical Reports on Biotech Equities -- Celgene, Dynavax Technologies, Keryx Biopharma, and Moleculin Biotech",9/6/2017 12:45:00 PM
DVAX,BRIEF-Dynavax Technologies says ‍on August 21 court entered an order preliminarily approving a proposed settlement​ (DVAX),9/1/2017 10:37:12 PM
DVAX,Vectura's AKITA Nebuliser To Be Used By Dynavax For Lung Cancer Programme ,8/16/2017 8:55:47 AM
DVAX,BRIEF-Dynavax announces exercise in full of over-allotment option (DVAX),8/15/2017 10:27:10 PM
DVAX,"GLPG's FLORA Blooms, DVAX, ESPR Price Offering, SGMO Abuzz, HRTX On Track ",8/10/2017 10:57:10 AM
DVAX,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar ",8/4/2017 8:47:30 AM
DVAX,Recent FDA Decisions and Clinical Trial Developments Influencing Current Biotech Run,8/3/2017 2:30:00 PM
DVAX,BRIEF-Dynavax reports Q2 loss per share $0.41 (DVAX),8/2/2017 12:17:03 PM
DVAX,"Gainers & Losers Of July 31: SBBP, AKCA, ACRX, ICPT, ZYNE... ",8/1/2017 4:54:01 AM
DVAX,"US STOCKS-Dow hits record high while tech retreats (BA, AAPL, TSLA, DISCA, CHTR, 9984, AMZN, DVAX, XOM, SBUX)",7/31/2017 10:32:03 PM
DVAX,"UPDATE 1-Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel (DVAX, GSK)",7/28/2017 11:26:05 PM
DVAX,"UPDATE 1-Dynavax hepatitis B vaccine works; raises safety issues -FDA (DVAX, GSK)",7/26/2017 3:38:03 PM
DVAX,Biotech Stocks Facing FDA Decision In July ,6/29/2017 6:48:24 AM
DVAX,Lifshitz & Miller LLP Files Amended Shareholder Derivative Lawsuit on Behalf of Dynavax Technologies Corporation,6/23/2017 9:48:00 PM
DVAX,"Breakfast Technical Briefing on Biotech Stocks -- Opko Health, Pain Therapeutics, Trevena, and Dynavax Technologies",6/20/2017 12:10:00 PM
DVAX,BRIEF-Point72 Asset Management reports 5.2 pct passive stake in Dynavax Technologies Corp (DVAX),6/6/2017 10:28:03 PM
DVAX,BRIEF-Dynavax presents updated data for sd-101 in combination with keytruda (DVAX),6/2/2017 10:58:07 PM
DVAX,"Biotech Stocks on Investors' Radar -- Progenics Pharma, Dynavax Technologies, Intrexon, and Heat Biologics",5/12/2017 12:20:00 PM
DVAX,"FDA Nod For TEVA, Cheers For PRTK, SRNE Hits Goal, SNY Launches Kids Toothpaste ",4/4/2017 5:03:37 AM
DVAX,BRIEF-Dynavax says PDUFA date for HEPLISAV-B remains unchanged (DVAX),4/3/2017 12:12:50 PM
DVAX,"Technical Reports on Biotech Stocks -- Nektar Therapeutics, Seattle Genetics, Dynavax Technologies, and BioMarin Pharma",3/13/2017 1:10:00 PM
DVAX,"Gainers & Losers Of Mar.1: DVAX, SKLN, FOLD, IPXL, QASM... ",3/2/2017 4:27:31 AM
DVAX,"AKRX, LXRX Get FDA Nod, KITE Flies Higher, SRPT Plunges On Dull Outlook ",3/1/2017 8:33:28 AM
